Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Prime Medicine Inc (NASDAQ: PRME) closed at $2.46 in the last session, up 13.89% from day before closing price of $2.16. In other words, the price has increased by $13.89% from its previous closing price. On the day, 5.71 million shares were traded. PRME stock price reached its highest trading level at $2.525 during the session, while it also had its lowest trading level at $2.15.
Ratios:
We take a closer look at PRME’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.07.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when Liu David R. bought 21,000 shares for $2.16 per share. The transaction valued at 45,402 led to the insider holds 20,219,945 shares of the business.
Liu David R. bought 21,000 shares of PRME for $31,196 on Jun 16 ’25. The 10% Owner now owns 20,198,945 shares after completing the transaction at $1.49 per share. On Jun 11 ’25, another insider, Liu David R., who serves as the 10% Owner of the company, bought 21,000 shares for $1.60 each. As a result, the insider paid 33,590 and bolstered with 20,177,945 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 322983232 and an Enterprise Value of 291336896. For the stock, the TTM Price-to-Sale (P/S) ratio is 83.89 while its Price-to-Book (P/B) ratio in mrq is 3.02. Its current Enterprise Value per Revenue stands at 75.751 whereas that against EBITDA is -1.457.
Stock Price History:
The Beta on a monthly basis for PRME is 1.63, which has changed by -0.51527095 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, PRME has reached a high of $6.75, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 65.95%, while the 200-Day Moving Average is calculated to be -7.40%.
Shares Statistics:
According to the various share statistics, PRME traded on average about 2.15M shares per day over the past 3-months and 3345780 shares per day over the past 10 days. A total of 131.16M shares are outstanding, with a floating share count of 51.69M. Insiders hold about 60.63% of the company’s shares, while institutions hold 28.66% stake in the company. Shares short for PRME as of 1748563200 were 17966546 with a Short Ratio of 8.38, compared to 1745971200 on 16526596. Therefore, it implies a Short% of Shares Outstanding of 17966546 and a Short% of Float of 26.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
